Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an observational study describing the real-life antipsychotic treatment during the hospitalisation of the patients due to acute psychotic episode.
In this NIS subject's data will be collected at one visit at the moment of discharge from the hospital.
The results of the study would help to characterise the discrepancy between current clinical practice and treatment guidelines, indicating that atypical antipsychotics are preferable and should be used in monotherapy during acute psychotic episodes in subjects with schizophrenia. Available evidence have revealed a frequent use of first-generation antipsychotics, polypharmacy, intramuscular route of administration and use of atypical antipsychotics in doses lower than recommended in registered summary of product characteristics.
RECONNECT-S GAMMA : A non-interventional study to observe real-life usage of atypical antipsychotics in the acute inpatient management of schizophrenia.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Acute psychotic episode in schizophrenia | Subjects suffering from schizophrenia being discharged from the hospital following hospitalisation due to acute psychotic episode |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Description of used atypical antipsychotic(s) during hospitalisation | The data will be collected at one visit at the moment of discharge from the hospital. | hospitalisation period, an expected average of 2 weeks (variable per patient) |
| Description of the daily dosage of atypical antipsychotic(s) during hospitalisation | The data will be collected at one visit at the moment of discharge from the hospital. | hospitalisation period, an expected average of 2 weeks (variable per patient) |
| Description of mode of administration of atypical antipsychotic(s) during hospitalisation | The data will be collected at one visit at the moment of discharge from the hospital. | hospitalisation period, an expected average of 2 weeks (variable per patient) |
| Measure | Description | Time Frame |
|---|---|---|
| Percent of patients with atypical antipsychotic as monotherapy | hospitalisation period, an expected average of 2 weeks (variable per patient) | |
| Percent of patients with combinations of antipsychotics. | hospitalisation period, an expected average of 2 weeks (variable per patient) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Subjects suffering from schizophrenia being discharged from the hospital following hospitalisation due to acute psychotic episode
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Radu TEODORESCU, Prof. | Spitalul Clinic of Psychiatry named after Prof. Dr. Alexandru Obregia, Romania | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Budapest | Hungary | ||||
| Research Site |
Not provided
Not provided
Not provided
Not provided
| Description of main criteria used for selection of an antipsychotic during hospitalisation. | hospitalisation period, an expected average of 2 weeks (variable per patient) |
| Description of the usage of psychometric scales in day to day practice, to evaluate the disease symptoms and thus the efficacy of treatment. | hospitalisation period, an expected average of 2 weeks (variable per patient) |
| Description of used concomitant psychiatric medication (other than atypical antipsychotic) during the hospitalization | hospitalisation period, an expected average of 2 weeks (variable per patient) |
| Description of the relationship between medication used during the hospitalization and maintenance therapy recommended upon discharge | hospitalisation period, an expected average of 2 weeks (variable per patient) |
| Description of the study population by collecting the following exploratory variables: demographic, educational, economical, social data, psychiatric and somatic health. | hospitalisation period, an expected average of 2 weeks (variable per patient) |
| Debrecen |
| Hungary |
| Research Site | Győr | Hungary |
| Research Site | Kistarcsa | Hungary |
| Research Site | Nyíregyháza | Hungary |
| Research Site | Szekszárd | Hungary |
| Research Site | Székesfehérvár | Hungary |
| Research Site | Daugavpils | Latvia |
| Research Site | Jelgava | Latvia |
| Research Site | Liepāja | Latvia |
| Research Site | Riga | Latvia |
| Research Site | Strenči | Latvia |
| Research Site | Bucharest | Romania |
| Research Site | Iași | Romania |
| ID | Term |
|---|---|
| D012559 | Schizophrenia |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided